Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1764-1767

  Nindl, Ingo ^a,c,d   Zumbach, Klaus ^b   Pawlita, Michael ^b   Teller, Karin ^a   Schneider, Achim ^a   Dürst, Matthias ^a  

^a Gynakologische Molekularbiologie   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MTM Laboratories   (Germany)

^d MTM Laboratories AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; UTERINE CERVIX CANCER; WART VIRUS;

AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RADIOIMMUNOPRECIPITATION ASSAY; REPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 0034123550     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315451     Document Type: Article

References (15)

1. 1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Lyon, France: IARC, 1995:64.
2. 2. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
3. 3. Muller M, Viscidi RP, Ulken V, et al. Antibodies to E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. J Invest Dermatol 1995;104: 138-41.
4. 4. Nindl I, Benitez-Bribiesca L, Berumen J, et al. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients. Arch Virol 1994;137:341-53.
5. 5. Meschede W, Zumbach K, Braspenning J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998;36:475-80.
6. 6. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-72.
7. 7. Icenogle JP, Sathya P, Miller DL, Tucker RA, Rawls WE. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 1991;184:101-7.
8. 8. Eschle D, Duerst M, ter Meulen J, et al. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol 1992;73:1829-32.
9. 9. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998;352:1441-2.
10. 10. Nindl I, Rindfleisch K, Lotz B, Schneider A, Duerst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int J Cancer 1999;82:203-7.
11. 11. Oltersdorf T, Seedorf K, Rowekamp W, Gissmann L. Identification of human papillomavirus type 16 E7 protein by monoclonal antibodies. J Gen Virol 1987;68:2933-8.
12. 12. Anders H, Rosenbauer J, Matiaske B. Schriftenreihe der AGEV: repraesentative verzehrstudie in der Bundesrepublik Deutschland incl. West-Berlin. Frankfurt: Umschau Verlag, 1990.
13. 13. Seedorf K, Krammer G, Duerst M, Suhai S, Rowekamp WG. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.
14. 14. Cheng G, Icenogle JP, Kirnbauer R, et al. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis 1995;172: 1584-7.
15. 15. Touze A, el Mehdaoui S, Sizaret PY, Mougin C, Munoz N, Coursaget P. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol 1998;36:2046-51.